- Research works
- 41 ▲ 56% vs 2013–17
- Citations
- 815 20.0 per fractional work
- Top-10% rate
- 26.8% record average 16.5%
- Open access
- 55% world 28%
Not ranked overall: Innovative Biologics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.0×. Every wedge is a field page.
- Immunology and Microbiology 5.0×
- Biochemistry, Genetics and Molecular Biology 3.6×
- Medicine 3.3×
- Veterinary 2.4×
- Dentistry 2.1×
- Pharmacology, Toxicology and Pharmaceutics 1.8×
- Chemistry 0.5×
- Neuroscience 0.4×
- Economics, Econometrics and Finance 0.4×
- Decision Sciences 0.4×
- Materials Science 0.3×
- Agricultural and Biological Sciences 0.3×
- Health Professions 0.2×
- Engineering 0.2×
- Psychology 0.1×
- Environmental Science 0.1×
- Computer Science 0.1×
- Social Sciences 0.0×
Which keywords describe research at Innovative Biologics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Clinical Trials, Epidemiology, Regenerative Medicine, Monoclonal Antibodies, Regulatory Challenges, Stem Cell Regulation, Therapeutic Antibodies and Healthcare-Associated Infections.
- Toxins
- Matrix Metalloproteinases
- Education
- Antibody Engineering
- Total Hip Replacement
- Staphylococcus aureus
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Bone Regeneration
- Extracellular Matrix
- Antibiotic Resistance
- Risk Factors
- Immunogenicity
- Angiogenesis
- Regeneration
- Biopharmaceuticals
- Therapeutic Antibodies
- Regulatory Challenges
- Inflammation
- Clinical Trials
- Epidemiology
- Regenerative Medicine
- Monoclonal Antibodies
- Stem Cell Regulation
- Healthcare-Associated Infections
- Glycosylation
- Pathogenesis
- Biomaterials
- Mesenchymal Stem Cells
- Tumor Microenvironment
- Cancer Immunotherapy
- Recombinant Proteins
- Clinical Practice Guidelines
- Immunotherapy
- Revision Surgery
- Tissue Engineering
- Vaccine
- Clinical Management
- Fc Receptors
- Osteoarthritis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology5▲ 3.3×27 topics
- Clinical Trials4▲ 17×9 topics
- Regenerative Medicine3▲ 36×5 topics
- Inflammation2▲ 2.6×12 topics
- Monoclonal Antibodies2▲ 42×3 topics
- Regulatory Challenges2▲ 68×1 topic
- Stem Cell Regulation2▲ 232×1 topic
- Therapeutic Antibodies2▲ 38×2 topics
- Healthcare-Associated Infections2▲ 39×3 topics
- Biopharmaceuticals2▲ 65×3 topics
- Glycosylation2▲ 20×3 topics
- Regeneration2▲ 23×3 topics
- Pathogenesis2▲ 7.1×6 topics
- Angiogenesis2▲ 9.2×6 topics
- Biomaterials2▲ 19×2 topics
- Immunogenicity2▲ 71×2 topics
- Mesenchymal Stem Cells2▲ 30×2 topics
- Risk Factors1▲ 3.2×6 topics
- Tumor Microenvironment1▲ 10×4 topics
- Antibiotic Resistance1▲ 7.7×4 topics
- Cancer Immunotherapy1▲ 22×3 topics
- Extracellular Matrix1▲ 13×5 topics
- Recombinant Proteins1▲ 61×2 topics
- Bone Regeneration1▲ 26×2 topics
- Clinical Practice Guidelines1▲ 4.8×3 topics
- Immune Checkpoint Blockade1▲ 49×1 topic
- Immunotherapy1▲ 4.3×4 topics
- PD-1 and PD-L11▲ 49×1 topic
- Revision Surgery1▲ 23×2 topics
- Staphylococcus aureus1▲ 35×2 topics
- Tissue Engineering1▲ 5.1×5 topics
- Total Hip Replacement1▲ 23×2 topics
- Vaccine1▲ 6.9×7 topics
- Antibody Engineering1▲ 25×1 topic
- Clinical Management1▲ 12×2 topics
- Education1▲ 1.88×2 topics
- Fc Receptors1▲ 25×1 topic
- Matrix Metalloproteinases1▲ 16×2 topics
- Osteoarthritis1▲ 20×3 topics
- Toxins1▲ 21×2 topics
Which research topics does Innovative Biologics (United States) publish most on?
By volume in 2022–2025: Osteoarthritis Treatment and Mechanisms, Knee injuries and reconstruction techniques, Total Knee Arthroplasty Outcomes and Biomedical Ethics and Regulation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Osteoarthritis Treatment and Mechanisms Rheumatology 1 works
- 2 Knee injuries and reconstruction techniques Surgery 1 works
- 3 Total Knee Arthroplasty Outcomes Surgery 0 works
- 4 Biomedical Ethics and Regulation Physiology 0 works
- 5 Shoulder Injury and Treatment Surgery 0 works
- 6 Protein purification and stability Molecular Biology 0 works
- 7 Genetics, Bioinformatics, and Biomedical Research Molecular Biology 0 works
- 8 Periodontal Regeneration and Treatments Urology 0 works
- 9 Pain Management and Treatment Anesthesiology and Pain Medicine 0 works
- 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Innovative Biologics (United States)'s research output changed?
Output in 2018–2022 was 56% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Herndon
- Volkswagen Group (United States)
- Fibertek (United States)
- National Student Clearinghouse Research Center
- International Institute of Islamic Thought
- Sotera Defense Solutions (United States)
- Virginia Innovation Partnership Corporation
- D-Tech (United States)
- Model Driven Solutions (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.